Effects of the Sodium-Glucose Cotransporter-2 Inhibitor Velagliflozin on Insulin Concentrations in Horses With Insulin Dysregulation
Authors
- Kristen Thane (ORCID: https://orcid.org/0000-0001-5647-7340)
- Tobias Warnken (ORCID: https://orcid.org/0000-0002-0741-4674)
- Nicholas Frank (ORCID: https://orcid.org/0000-0002-0564-7976)
- Rebecca Klee (ORCID: https://orcid.org/0000-0002-9219-8581)
- R. Voth
- Victor Chukwu
Institutions
- Tufts University (US)
- Boehringer Ingelheim (Germany) (DE)
- Boehringer Ingelheim (China) (CN)
- Boehringer Ingelheim (United States) (US)
- Mississippi State University (US)
Publication Details
- Journal
- Journal of Veterinary Internal Medicine
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1111/jvim.70256
- Citations
- 1
- Primary Topic
- Veterinary Equine Medical Research
- Type
- article
- Field-Weighted Citation Impact
- 2.73
Funders
- American College of Veterinary Internal Medicine